about
Neural progenitors organize in small-world networks to promote cell proliferationIn vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XLLiver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells.Intraneuronal trafficking of G-protein-coupled receptors in vivo.Modulation of the generation of dopaminergic neurons from human neural stem cells by Bcl-X(L): mechanisms of action.Progress in stem cell therapy for major human neurological disorders.Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.An Update on Human Stem Cell-Based Therapy in Parkinson's Disease.Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells.Bcl-XL modulates the differentiation of immortalized human neural stem cells.The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo.Stem cells as in vitro model of Parkinson's disease.Intrathalamic striatal grafts survive and affect circling behaviour in adult rats with excitotoxically lesioned striatum.Intrathalamic implants of GABA-releasing polymer matrices reduce motor impairments in rats with excitotoxically lesioned striata.Ca2+ and cAMP signaling in human embryonic stem cell-derived dopamine neurons.Acute and chronic acetylcholinesterase inhibition regulates in vivo the localization and abundance of muscarinic receptors m2 and m4 at the cell surface and in the cytoplasm of striatal neurons.Low-level tyrosine hydroxylase (TH) expression allows for the generation of stable TH+ cell lines of human neural stem cells.Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells.Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.GABA(A) receptor subunit expression in intrastriatal striatal grafts comparison between normal developing striatum and developing striatal grafts.Time course of striatal, pallidal and thalamic alpha 1, alpha 2 and beta 2/3 GABAA receptor subunit changes induced by unilateral 6-OHDA lesion of the nigrostriatal pathway.Previous dopaminergic innervation is not necessary for the development of dopamine supersensitivity in rat striatal neurons.Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.DNGR-1(+) dendritic cells are located in meningeal membrane and choroid plexus of the noninjured brain.Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin.Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: Interaction between the serotonergic, glutamatergic, and dopaminergic systemsCortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptorsGABAA receptor alpha 1-subunit-immunopositive neurons in the rat striatumSemiquantitative immunocytochemical analysis of GABAA receptor subunit expression in the rat neostriatumAnalysis of the inter-alpha-trypsin inhibitor polymorphism in west Africa: description of a new allele, ITI*7Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: interaction between the serotonergic, glutamatergic, and dopaminergic systemsDistribution of ITI phenotypes in the Iberian Peninsula: Negative correlation between ITI*3 frequencies and latitude in human populationsNeuronal and Glial Differentiation of Human Neural Stem Cells Is Regulated by Amyloid Precursor Protein (APP) LevelsAβ42 Peptide Promotes Proliferation and Gliogenesis in Human Neural Stem CellsEffects of chlorpyrifos on cell death and cellular phenotypic specification of human neural stem cells
P50
Q30539060-63306832-1AD4-456F-A279-0FE598100246Q33744707-44106775-F98F-4C6F-AD11-C25928FF9A7CQ35005980-70EC189F-0083-4FDD-BD7E-BDF66EC3339EQ36380363-BD55CF42-2890-4E3C-9C0A-813215F630F1Q37962756-6755D5F6-C47F-4250-8350-B89A6A523FAAQ38107439-C2D1FC57-E5B9-47C4-B4A4-19E13494EDFAQ38372922-48FB1877-53E0-4520-B301-50EC46A127ABQ38509251-16D07365-6F07-44FA-AEA8-FFCDB37AFE58Q39804668-DCD0738F-0B61-4F4C-9AFF-7D0B42416D26Q40098527-025C729F-F629-4FA2-B807-66F2C805F2A6Q40485815-0B0B8835-1A0B-4D80-A3AB-A31A212FE836Q42159528-B12E2918-75EB-4869-943E-4D0122B92AA5Q42514730-C12C2898-2EED-48AC-9A3A-5D84F5918956Q42527416-9C2AEF4A-6295-460F-AFCC-28812B4DEC92Q43204155-32025537-E34F-4378-B23A-55ABC72D1AC6Q44047012-413A2F6B-7818-41BA-8756-F481C37722DEQ44765399-71D6C357-250E-495A-8565-D771D8A8D620Q47703114-8410D584-8271-44E8-A231-178E8BCE24D5Q48178443-79ACBA83-B5BD-4947-9FFD-CCE8CA59BE6BQ48565035-62547AAC-2653-44AF-90DA-F4CE99AA1F7DQ48617812-E38131E6-EBF4-41AF-8B35-84F05E6F157EQ49056991-F992AF17-0109-4671-8232-D28D9400D2AFQ49137803-5BD74CCF-B9A3-4058-855A-97A40C612242Q50259401-604ACB4C-763E-46C2-BA12-C3BBC242C51BQ54714854-ADE06A38-FF4A-4C45-9643-7E3DDC2F9C06Q59463634-89D580F7-C861-4CC5-9E89-0297F9B7449EQ71066208-4C4756E6-BB80-40C2-8777-78167F24929CQ71546020-FA9501AE-0A95-45D0-8924-7DC7DF426403Q71671497-0785F0C5-5C97-4131-9796-D2CACE38429FQ71674385-9812C360-BBB5-418C-8998-904B6CA81783Q73405612-BC7C3FC5-D665-403A-A8FF-9719598C3A41Q88161862-6F0E01BA-C548-4CBB-8B4F-B9C373A1692CQ89036230-FF68E839-8FDB-47D0-A81F-241E5702213EQ91796479-C44FB372-3B6B-4E91-9286-4399A664EB0AQ92345357-4F2977CC-5DAF-4E4F-BF52-447DE5970A24
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isabel Liste
@ast
Isabel Liste
@en
Isabel Liste
@es
Isabel Liste
@nl
Isabel Liste
@sl
type
label
Isabel Liste
@ast
Isabel Liste
@en
Isabel Liste
@es
Isabel Liste
@nl
Isabel Liste
@sl
prefLabel
Isabel Liste
@ast
Isabel Liste
@en
Isabel Liste
@es
Isabel Liste
@nl
Isabel Liste
@sl
P106
P21
P31
P496
0000-0002-3294-9558